Navigation Links
RSB Spine, LLC, Announces FDA Clearance for Its InterPlate(TM) C-PS and L-PS Interbody Spacers
Date:1/28/2010

CLEVELAND, Jan. 28 /PRNewswire/ -- RSB Spine, LLC, today announced that the U.S. Food and Drug Administration has approved the company's 510(k) application to permit the marketing of its InterPlate™ C-PS and L-PS Interbody Spacers.

RSB Spine Chief Executive Officer John A. Redmond said: "We are very excited about this new clearance, since it gives our distributors two additional products to offer customers seeking greater options in Zero-Profile® technologies. Our InterPlate portfolio now provides surgeons with the most unique implant combinations on the market."

"Zero-Profile technologies comprise one of the fastest growing segments in the spinal industry," said Mike O'Neill, president of Paradigm BioDevices. "RSB Spine is the only company with a full-line modular interbody platform offering a complete array of material and mechanical loading options that is also code compliant."

RSB Spine is a privately held medical device company focused on developing innovative spinal implants with a focus on modular fusion products. News releases and other information on the company are available on the Internet at: http://www.rsbspine.com.

Zero-Profile® is a registered Service Mark of Paradigm BioDevices, Inc., Rockland, MA.

SOURCE RSB Spine, LLC

RELATED LINKS
http://www.rsbspine.com

'/>"/>

SOURCE RSB Spine, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology
2. RSB Spine, LLC Announces First Implantation of the InterPlate(TM) L for the Lumbar Spine
3. Drug Safety Firm BioSoteria Announces Exponential Growth in 2009
4. Sinovac Announces Upsizing and Pricing of Common Share Offering
5. Sudek of Tech Coast Angels Announces Networks Increased Commitment to Entrepreneurship and Innovation Through New Easy-Access Programs
6. Waytronx Announces Agreement for Development and Production of Its GASPT2 Device With UK-Based Ingenion Design Limited
7. YM BioSciences announces FDA clearance for two ongoing Phase II nimotuzumab trials into USA
8. China YCT International Group, Inc. Announces That the State Intellectual Property Office of the Peoples Republic of China has Approved a Patent to its Operating Subsidiary, Shandong Spring Pharmaceutical Co. Ltd.
9. Firmex Announces Virtual Data Room Enhancements for Large Projects
10. UMass Boston's Venture Development Center Announces New Bio-Science Partner
11. Healthcare Data Solutions Announces New Mobile Application, PrescriberPRO Mobile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... Melbourne, FL (PRWEB) , ... May 25, 2016 , ... ... of eight she tore her cruciate ligament in her left knee. Lady’s owner Hannah ... , a central Florida board-certified veterinary surgeon, to repair her cruciate ligament and help ...
(Date:5/24/2016)... ... 24, 2016 , ... Cell therapies for a range of ... research at Worcester Polytechnic Institute (WPI) that yielded a newly patented method of ... The novel method, developed by WPI faculty members Raymond Page, PhD, professor of ...
(Date:5/24/2016)... Jolla, CA (PRWEB) , ... May 24, 2016 , ... ... financial planning for corporate executives and entrepreneurs, held The Future of San Diego Life ... in the San Diego life science community attended the event with speakers Dr. Rich ...
(Date:5/23/2016)... ... ... for blood donations in South Texas and across the nation is growing. , But according ... donations are on the decline. In fact, donations across the country are at their lowest ... in the last four years alone. , There is no substitute for blood. , “We ...
Breaking Biology Technology:
(Date:3/22/2016)... PROVO and SANDY, ... Screening Ontario (NSO), which operates the highest sample volume ... testing, and Tute Genomics and UNIConnect, leaders in clinical ... today announced the launch of a project to establish ... testing panel. NSO has been contracted ...
(Date:3/15/2016)... JERUSALEM , March 15, 2016 ... Jerusalem , the technology-transfer company of the Hebrew University, ... developer of remote sensing technology of various human biological ... funding, raising $2.0 million from private investors. ... technology, based on the detection of electromagnetic emissions from ...
(Date:3/10/2016)... 2016 --> ... "Identity and Access Management Market by Component (Provisioning, Directory ... by Organization Size, by Deployment, by Vertical, and by ... The market is estimated to grow from USD 7.20 ... at a Compound Annual Growth Rate (CAGR) of 12.2% ...
Breaking Biology News(10 mins):